122 related articles for article (PubMed ID: 35933851)
1. Inhibition of adenosine deaminase activity reverses resistance to the cytotoxic effect of high adenosine levels in cervical cancer cells.
Monroy-Mora A; de Lourdes Mora-García M; Alheli Monroy Mora K; Hernández-Montes J; García-Rocha R; Don-López CA; Weiss-Steider B; Montesinos-Montesinos JJ; Monroy-García A
Cytokine; 2022 Oct; 158():155977. PubMed ID: 35933851
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
Mora-García ML; Ávila-Ibarra LR; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Don-López CA; Gutiérrez-Serrano V; Titla-Vilchis IJ; Fuentes-Castañeda MC; Monroy-Mora A; Jave-Suárez LF; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Cell Immunol; 2017 Oct; 320():46-55. PubMed ID: 28950987
[TBL] [Abstract][Full Text] [Related]
3. Adenosine deaminase inhibitor EHNA exhibits a potent anticancer effect against malignant pleural mesothelioma.
Nakajima Y; Kanno T; Nagaya T; Kuribayashi K; Nakano T; Gotoh A; Nishizaki T
Cell Physiol Biochem; 2015; 35(1):51-60. PubMed ID: 25547995
[TBL] [Abstract][Full Text] [Related]
4. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors.
Barankiewicz J; Danks AM; Abushanab E; Makings L; Wiemann T; Wallis RA; Pragnacharyulu PV; Fox A; Marangos PJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):1230-8. PubMed ID: 9399998
[TBL] [Abstract][Full Text] [Related]
5. Effects of an adenosine kinase inhibitor and an adenosine deaminase inhibitor on accumulation of extracellular adenosine by equine articular chondrocytes.
Tesch AM; MacDonald MH; Kollias-Baker C; Benton HP
Am J Vet Res; 2002 Nov; 63(11):1512-9. PubMed ID: 12428660
[TBL] [Abstract][Full Text] [Related]
6. Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.
Hashemi M; Karami-Tehrani F; Ghavami S; Maddika S; Los M
Cell Prolif; 2005 Oct; 38(5):269-85. PubMed ID: 16202036
[TBL] [Abstract][Full Text] [Related]
7. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine.
Duncan GS; Wolberg G; Schmitges CJ; Deeprose RD; Zimmerman TP
J Immunopharmacol; 1982; 4(1-2):79-100. PubMed ID: 6296234
[TBL] [Abstract][Full Text] [Related]
9. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis.
Carson DA; Seegmiller JE
J Clin Invest; 1976 Feb; 57(2):274-82. PubMed ID: 176177
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
Ullman B; Cohen A; Martin DW
Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of inhibition of calf intestinal adenosine deaminase by (+)- and (-)-erythro-9-(2-hydroxy-3-nonyl)adenine.
Porter DJ; Abushanab E
Biochemistry; 1992 Sep; 31(35):8216-20. PubMed ID: 1525161
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1.
García-Rocha R; Monroy-García A; Hernández-Montes J; Weiss-Steider B; Gutiérrez-Serrano V; Del Carmen Fuentes-Castañeda M; Ávila-Ibarra LR; Don-López CA; Torres-Pineda DB; de Lourdes Mora-García M
Cytokine; 2019 Jun; 118():71-79. PubMed ID: 30301599
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy.
Singhal D; Anderson BD
J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908
[TBL] [Abstract][Full Text] [Related]
14. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
[TBL] [Abstract][Full Text] [Related]
15. Regulation of thymocyte proliferation by endogenous adenosine and adenosine deaminase.
Sandberg G
Int J Immunopharmacol; 1983; 5(4):259-65. PubMed ID: 6605314
[TBL] [Abstract][Full Text] [Related]
16. Separation between ischemic and reperfusion injury by site specific entrapment of endogenous adenosine and inosine using NBMPR and EHNA.
Abd-Elfattah AS; Wechsler AS
J Card Surg; 1994 May; 9(3 Suppl):387-96. PubMed ID: 8069025
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of apoptosis induced by purine nucleosides in astrocytes.
Di Iorio P; Kleywegt S; Ciccarelli R; Traversa U; Andrew CM; Crocker CE; Werstiuk ES; Rathbone MP
Glia; 2002 May; 38(3):179-90. PubMed ID: 11968056
[TBL] [Abstract][Full Text] [Related]
18. Adenosine deaminase inhibitor in cardioplegia enhanced function preservation of the hypothermically stored rat heart.
Zhu Q; Yang X; Claydon MA; Hicks GL; Wang T
Transplantation; 1994 Jan; 57(1):35-40. PubMed ID: 8291112
[TBL] [Abstract][Full Text] [Related]
19. Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb
Lee S; Park H; Ki Y; Lee H; Han MS
Sensors (Basel); 2019 Jun; 19(12):. PubMed ID: 31216643
[TBL] [Abstract][Full Text] [Related]
20. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
